The effects of statin dose, lipophilicity, and combination of statins plus ezetimibe on circulating oxidized low-density lipoprotein levels: a systematic review and meta-analysis of randomized controlled trials (2021)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1155/2021/9661752
- Subjects: ARTERIOSCLEROSE; HIPERCOLESTEROLEMIA; FATORES DE RISCO; ESTATINAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Mediators of inflammation
- ISSN: 0962-9351
- Volume/Número/Paginação/Ano: v. 2021, article ID 9661752, 12p, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
JAMIALAHMADI, Tannaz et al. The effects of statin dose, lipophilicity, and combination of statins plus ezetimibe on circulating oxidized low-density lipoprotein levels: a systematic review and meta-analysis of randomized controlled trials. Mediators of inflammation, v. 2021, 2021Tradução . . Disponível em: https://doi.org/10.1155/2021/9661752. Acesso em: 14 fev. 2026. -
APA
Jamialahmadi, T., Baratzadeh, F., Reiner, Z., Simental-mendia, L. E., Xu, S., Susekov, A. V., et al. (2021). The effects of statin dose, lipophilicity, and combination of statins plus ezetimibe on circulating oxidized low-density lipoprotein levels: a systematic review and meta-analysis of randomized controlled trials. Mediators of inflammation, 2021. doi:10.1155/2021/9661752 -
NLM
Jamialahmadi T, Baratzadeh F, Reiner Z, Simental-mendia LE, Xu S, Susekov AV, Santos Filho RD dos, Sahebkar A. The effects of statin dose, lipophilicity, and combination of statins plus ezetimibe on circulating oxidized low-density lipoprotein levels: a systematic review and meta-analysis of randomized controlled trials [Internet]. Mediators of inflammation. 2021 ; 2021[citado 2026 fev. 14 ] Available from: https://doi.org/10.1155/2021/9661752 -
Vancouver
Jamialahmadi T, Baratzadeh F, Reiner Z, Simental-mendia LE, Xu S, Susekov AV, Santos Filho RD dos, Sahebkar A. The effects of statin dose, lipophilicity, and combination of statins plus ezetimibe on circulating oxidized low-density lipoprotein levels: a systematic review and meta-analysis of randomized controlled trials [Internet]. Mediators of inflammation. 2021 ; 2021[citado 2026 fev. 14 ] Available from: https://doi.org/10.1155/2021/9661752 - Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension
- Familial hypercholesterolaemia: PCSK9 inhibitors are coming [comentário]
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
- Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
- USPSTF recommendation on screening for lipid disorders in children and adolescents. [Carta]
- Down the rabbit hole: reviewing the evidence for primary prevention of cardiovascular disease in people with obesity
- Relation Between Self-Reported Physical Activity Level, Fitness, and Cardiometabolic Risk
- Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know
- The Role of Statins in Current Guidelines
Informações sobre o DOI: 10.1155/2021/9661752 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
